Samsung C&T028260
Samsung C&T (028260) Amended Rights Offering, Nov 5, 2026
Filing date ·
Samsung C&T subsidiary Samsung Biologics corrected its disclosure on November 5, 2026 to set the final issue price for its rights offering at KRW 1.174 million…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.